Early Age-Related Hearing Loss Investigation Pilot Study (P-EARLHI)

University of South Florida logo

University of South Florida

Status

Enrolling

Conditions

Hearing Loss

Treatments

Device: Phonak Audeo Lumity Receiver in Canal Hearing Aid

Study type

Interventional

Funder types

Other

Identifiers

NCT05970211
005599

Details and patient eligibility

About

The purpose of this clinical trial pilot is to obtain feasibility and pilot data necessary to inform the hearing intervention being designed for a larger R01 clinical trial that seeks to determine whether best practice hearing aid intervention impacts hearing-related outcomes in adults with hearing loss aged 55 to 75 years. Secondary purposes include: To determine what effects best practice hearing aid intervention has on physical, social, and quality of life outcomes in adults with hearing loss aged 55 to 75 years.

Full description

This is an observational pre-post intervention feasibility study. In addition to the objective finding that adults with hearing loss experience higher rates of cognitive decline, they also tend to report lesser degrees of physical activity and increased cognitive fatigue, which is the feeling of tiredness or having a lack of energy. Unfortunately, the mechanism by which hearing loss relates to physical activity and fatigue, and the effect of hearing aids as an intervention to improve these factors, is unclear. Thus, the purpose of this study is twofold: First, we will establish the feasibility of administering a best practices hearing aid intervention to a sample of adults from the target age range of 55 - 75 years old to inform the larger clinical trial; Second, we will collect pilot data to explore the relationships between hearing loss, physical activity, socialization, fatigue and hearing-related outcomes before and after hearing aid intervention. There are no experimental or investigational devices or agents used in this study. We are providing best-practices standard of care hearing intervention including hearing aids. We are additionally tracking activity using the ActiGraph wGT3X-BT, an FDA-approved Class II medical device that tracks continuous, high resolution physical activity and sleep/wake information. Participation involves a minimum of 6 in-office study visits. Intervention sessions occur approximately 2 weeks apart, with a final long-term outcome session occurring approximately 6-months post the baseline intervention session. Significant others of participants are invited to join the study and contribute data related to their own quality of life and their observations of the effects of the hearing intervention on the participant.

Enrollment

40 estimated patients

Sex

All

Ages

55 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults aged 55 to 75 years old with little or no experience with hearing aids
  • English or Spanish speakers

Exclusion criteria

  • Unable to complete written questionnaires on a tablet without assistance
  • Refer for cognitive screening score based on criteria using the Mini Mental State Examination

Trial design

40 participants in 1 patient group

Hearing Intervention Group
Experimental group
Description:
Adults aged 55-75 with hearing loss who have little/no prior experience with hearing aids will be enrolled in the hearing intervention group.
Treatment:
Device: Phonak Audeo Lumity Receiver in Canal Hearing Aid

Trial contacts and locations

0

Loading...

Central trial contact

Michelle Arnold, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems